Fetal Growth Restriction clinical trials at University of California Health
1 research study open to eligible people
open to eligible females ages 18-60
This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.
Our lead scientists for Fetal Growth Restriction research studies include Nasim Sobhani, MD.